Companies in healthcare and life sciences, defense, transportation, entertainment and other industries are tapping the $500 billion in corporate relief and $377 billion in small business relief that Congress included in the $2 trillion COVID-19 stimulus law. The Coronavirus Aid, Relief and Economic Security Act (CARES Act, Pub. L. No. 116-136) earmarks $100 billion for hospitals and healthcare providers and another $27 billion for vaccines and other therapies and personal protective equipment.
While some in these industries are accustomed to living under the lens of the government's enforcement microscope, others are less prepared to minimize the risk of being swept up in an inevitable wave of criminal and civil actions that will be brought against companies and individuals that seek and receive stimulus funding.